ZA200606070B - Substituted quinolines and their use as mycrobacterial inhibitors - Google Patents

Substituted quinolines and their use as mycrobacterial inhibitors

Info

Publication number
ZA200606070B
ZA200606070B ZA200606070A ZA200606070A ZA200606070B ZA 200606070 B ZA200606070 B ZA 200606070B ZA 200606070 A ZA200606070 A ZA 200606070A ZA 200606070 A ZA200606070 A ZA 200606070A ZA 200606070 B ZA200606070 B ZA 200606070B
Authority
ZA
South Africa
Prior art keywords
mycrobacterial
inhibitors
substituted quinolines
quinolines
substituted
Prior art date
Application number
ZA200606070A
Other languages
English (en)
Inventor
Jerome Emile Georges Guillemont
Elisabeth Therese Jeanne Pasquier
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA200606070B publication Critical patent/ZA200606070B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200606070A 2004-01-23 2006-07-21 Substituted quinolines and their use as mycrobacterial inhibitors ZA200606070B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53876804P 2004-01-23 2004-01-23

Publications (1)

Publication Number Publication Date
ZA200606070B true ZA200606070B (en) 2007-12-27

Family

ID=34807224

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200606070A ZA200606070B (en) 2004-01-23 2006-07-21 Substituted quinolines and their use as mycrobacterial inhibitors

Country Status (19)

Country Link
US (1) US7338949B2 (pt)
EP (1) EP1711492B1 (pt)
JP (1) JP4773975B2 (pt)
KR (1) KR101150172B1 (pt)
CN (1) CN1910177B (pt)
AP (1) AP2188A (pt)
AT (1) ATE392423T1 (pt)
AU (1) AU2005206330B2 (pt)
BR (1) BRPI0507076B8 (pt)
CA (1) CA2553266C (pt)
DE (1) DE602005006101T2 (pt)
EA (1) EA011359B1 (pt)
ES (1) ES2306082T3 (pt)
IL (1) IL177013A0 (pt)
NO (1) NO337705B1 (pt)
NZ (1) NZ547277A (pt)
UA (1) UA85570C2 (pt)
WO (1) WO2005070924A1 (pt)
ZA (1) ZA200606070B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2554049C (en) * 2004-01-29 2012-12-18 Janssen Pharmaceutica N.V. Quinoline derivatives for use as mycobacterial inhibitors
CA2528849C (en) * 2005-06-08 2014-01-14 Janssen Pharmaceutica N.V. Quinoline derivatives as antibacterial agents
JO2855B1 (en) 2005-08-03 2015-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JO2837B1 (en) 2005-08-03 2014-09-15 جانسن فارمسيتكا ان في Quinoline derivatives acting as antibacterial agents
WO2007022946A1 (de) 2005-08-21 2007-03-01 Abbott Gmbh & Co. Kg Heterocyclische verbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren
JO2684B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان في Quinoline antibacterial derivatives
JO2970B1 (en) 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2685B1 (en) 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان في Quinoline antibacterial derivatives
JO3271B1 (ar) 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
CA2711912A1 (en) * 2008-01-14 2009-07-23 Jyoti Chattopadhyaya Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents
CN104254527B (zh) * 2012-04-27 2017-05-31 詹森药业有限公司 抗菌的喹啉衍生物
ES2607879T3 (es) * 2012-04-27 2017-04-04 Janssen Pharmaceutica N.V. Derivados de quinolina antibacterianos
ES2911341T3 (es) * 2015-04-29 2022-05-18 The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo Composiciones antifitopatogénicas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998018326A1 (en) * 1996-10-28 1998-05-07 Department Of The Army, U.S. Government Compounds, compositions and methods for treating antibiotic-resistant infections
CN100525766C (zh) * 1997-06-02 2009-08-12 詹森药业有限公司 用作平滑肌细胞增殖抑制剂的（咪唑-5-基）甲基-2-喹啉酮衍生物
US6103905A (en) 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
WO1998057931A2 (en) * 1997-06-19 1998-12-23 Sepracor Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
ATE375794T1 (de) * 2000-02-24 2007-11-15 Janssen Pharmaceutica Nv Dosierschema enthaldend farnesyl protein transferase inhibitoren für die behandlung von krebs
CN1703403A (zh) * 2000-10-02 2005-11-30 詹森药业有限公司 趋代谢的谷氨酸盐受体拮抗剂
ATE463482T1 (de) 2002-07-25 2010-04-15 Janssen Pharmaceutica Nv Chinolinderivate und deren verwendung als mycobakterielle inhibitoren

Also Published As

Publication number Publication date
KR101150172B1 (ko) 2012-05-25
DE602005006101T2 (de) 2009-07-02
BRPI0507076B1 (pt) 2019-06-25
CN1910177B (zh) 2010-05-05
AU2005206330A1 (en) 2005-08-04
WO2005070924A8 (en) 2006-05-11
US7338949B2 (en) 2008-03-04
EA011359B1 (ru) 2009-02-27
KR20060127016A (ko) 2006-12-11
CA2553266A1 (en) 2005-08-04
WO2005070924A1 (en) 2005-08-04
AP2006003693A0 (en) 2006-08-31
CN1910177A (zh) 2007-02-07
UA85570C2 (uk) 2009-02-10
AU2005206330B2 (en) 2010-09-16
US20070082895A1 (en) 2007-04-12
IL177013A0 (en) 2006-12-10
CA2553266C (en) 2013-03-12
JP2007518775A (ja) 2007-07-12
EP1711492B1 (en) 2008-04-16
BRPI0507076B8 (pt) 2021-05-25
ATE392423T1 (de) 2008-05-15
NZ547277A (en) 2009-08-28
EP1711492A1 (en) 2006-10-18
JP4773975B2 (ja) 2011-09-14
ES2306082T3 (es) 2008-11-01
DE602005006101D1 (de) 2008-05-29
NO20063747L (no) 2006-08-22
NO337705B1 (no) 2016-06-06
AP2188A (en) 2010-12-14
BRPI0507076A (pt) 2007-06-19
EA200601363A1 (ru) 2006-12-29
HK1100927A1 (zh) 2007-10-05

Similar Documents

Publication Publication Date Title
IL177012A0 (en) Quinoline derivatives and use thereof as mycobacterial inhibitors
EG25993A (en) Heteroaromatic quinoline compounds and their use as pde10 inhibitors
EP1742627A4 (en) PDE4B HEMMER AND ITS USE
ZA200500680B (en) Quinoline derivatives and their use as mycrobacterial inhibitors
ZA200701635B (en) Quinazolinone derivatives and their use as B-Raf inhibitors
IL190055A0 (en) Quinolines and their therapeutic use
IL181670A0 (en) Substituted phenylaminothiazoles and use thereof
ZA200701366B (en) Quinazolinone derivatives and their use as B-Raf inhibitors
SI2589599T1 (sl) Novi hidroksi-6-heteroarilfenantridini in njihova uporaba kot PDE4 inhibitorji
ZA200606070B (en) Substituted quinolines and their use as mycrobacterial inhibitors
IL176772A0 (en) Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors
PL380189A3 (pl) Azolidynokarbonitryle i ich zastosowanie jako inhibitory DPP-IV
PL2215908T3 (pl) 2-alkilo-cykloalk(en)ylo-karboksamidy i ich zastosowanie jako fungicydów
EP1810976A4 (en) BENZONAPHTHACENEGLYCOSIDE DERIVATIVE AND THE USE THEREOF
ZA200802683B (en) Quinolines and their therapeutic use
IL177271A0 (en) Heparanase inhibitors and uses thereof
ZA200606671B (en) Novel thio-containing hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
GB0401243D0 (en) Compounds and their use
GB0401244D0 (en) Compounds and their use
GB0402903D0 (en) Compounds and their use